Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001437749-24-008575 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | PBYI | AUERBACH ALAN H | Pres, CEO, Dir, 10% | A - Grant | $0.00 | +6,577 | 7.10M | +0.1% | $0 |
| D | 2024-03-19 | 2024-03-15 | PBYI | AUERBACH ALAN H | Pres, CEO, Dir, 10% | A - Grant | $0.00 | +9,047 | 9,047 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 6,577 | $0.00 | 7,104,320 | D | — | — | (F1) Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards. (F2) Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-03-15 | A | A | 9,047 | $0.00 | 9,047 | D | $5.00 · — to 2034-03-14 | 9,047 Common Stock | (F1) Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards. (F3) Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events. |